Neuphoria Therapeutics Inc.

NEUP · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$14,210,745$12,608$8,056$23,090
Short-Term Investments$0$0$0$0
Receivables$11,948$127$284$4,667
Inventory$0$0$0$0
Other Curr. Assets$818,138$459$531$1,005
Total Curr. Assets$15,040,831$13,194$8,871$28,762
Property Plant & Equip (Net)$105,383$219$222$464
Goodwill$8,638,609$8,690$5,787$8,852
Intangibles$4,804,791$5,468$4,081$6,768
Long-Term Investments$0$79$53$0
Tax Assets$0$0$381$0
Other NC Assets$0-$1$0$82
Total NC Assets$13,548,783$14,455$10,523$16,166
Other Assets$0$0$0$0
Total Assets$28,589,614$27,649$19,394$44,927
Liabilities
Payables$1,154,369$2,244$958$1,071
Short-Term Debt$116,314$155$98$110
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,950,077$1,430$767$1,127
Total Curr. Liab.$4,220,760$3,829$1,823$2,308
LT Debt$0$118$160$367
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$495,113$964$1,115$1,237
Other NC Liab.$4,871,167$5,248$1,645$1,864
Total NC Liab.$5,366,280$6,330$2,919$3,468
Other Liabilities$0$0$0$0
Cap. Leases$0$240$160$477
Total Liabilities$9,587,040$10,159$4,742$5,777
Equity
Pref Stock$0$0$0$0
Common Stock$19$0$0$149,755
Retained Earnings-$178,346,703-$177,977-$108,158-$119,219
AOCI-$2,845,066-$3,014$3,195$8,615
Other Equity$200,194,324$198,481$119,614$0
Total Equity$19,002,574$17,490$14,651$39,151
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$28,589,614$27,649$19,394$44,927
Net Debt-$14,094,431-$12,335-$7,799-$22,612